September 18, 2012

In part two, DSN asks pharmacists to name their top OTC brand recommendations across 15 core product categories.

September 18, 2012

Boehringer Ingelheim Pharmaceuticals has launched a drug for treating chronic obstructive pulmonary disease, the company said Tuesday.

September 18, 2012

The Food and Drug Administration has approved a treatment for a disease that causes brittle nails.

September 18, 2012

A trillion of anything is difficult to wrap one’s head around, whether it’s the number of grains of sand on a beach or stars in the sky. It’s so much easier for the human mind to look at such a quantity as the sum of its parts rather than on the basis of its individual components.


September 18, 2012

The interest in healthcare reform has reached a new high, especially in light of the decision by the U.S. Supreme Court to uphold the Patient Protection and Affordable Care Act, yet there's no denying that consumers are still unclear as to the impact on their personal healthcare and insurance issues. That being said, Americans see a need for change as they battle rising costs and a lack of access to care, and many are saying "aye" to healthcare reform, according to the most recent Patient Views infographic. To be specific, two-thirds of respondents say they support healthcare reform, according to an exclusive survey of nearly 800 patients conducted by AccentHealth and DSN in late July and early August.

September 18, 2012

Earlier this summer Hyland’s introduced its Leg Cramps Ointment to complement its line of homeopathic Leg Cramps tablets. Expect the leg cramp market to grow.

September 18, 2012

It’s a little hard not to say “Oh, how the mighty have fallen” when a retailer announces that it will give away for free what was once the world’s top-selling drug. But for retailers, it also makes good business sense.


September 18, 2012

Over the last few years of DSN’s coverage of the impending patent cliff and how it would affect the generic drug industry, IMS Health VP industry relations Doug Long predicted that the gradual commoditization of primary care drugs — long the lifeblood of generic drug makers — would lead to consolidation of the industry.


September 18, 2012

Generic drug makers Hospira, Sagent Pharmaceuticals and Teva Pharmaceutical Industries have launched generic versions of a chemotherapy drug made by Sanofi, the three companies said last month.


September 18, 2012

2012 is turning out to be a pretty important year for generic drugs, important enough that some of the things happening over the past several months have begged comparison to 1984, probably the biggest milestone year for the industry.


September 18, 2012

For branded drug makers, the pharmaceutical patent cliff has never loomed higher or steeper. The exposure of so many of the world’s biggest-selling medicines to generic competition for the first time is redefining the pricing model for many of the most widely prescribed classes of pharmaceuticals.

September 17, 2012

The Food and Drug Administration has approved a generic ulcer treatment made by Wockhardt, the Indian drug maker said Monday.

September 17, 2012

A lot of people have quite a few things to say about healthcare reform, whether they favor or oppose it. But supporters of the law show an altruistic sensibility and an understanding of how the law would benefit other Americans, according to an exclusive survey of nearly 800 patients conducted by AccentHealth and DSN in late July and early August.

September 17, 2012

VoicePort has launched its new appointment scheduler services application.

September 17, 2012

Walgreens and Rx Response on Monday announced a new healthcare collaboration developed to help ensure patient access to medications following a natural disaster.

September 14, 2012

The Food and Drug Administration has granted regulatory approval for a generic drug to treat tension headaches.

September 14, 2012

The Food and Drug Administration on Thursday alerted the public that certain external analgesics have been associated with burns.

September 14, 2012

Two generic drug makers have settled with a subsidiary of Johnson & Johnson and another company concerning a drug used to treat attention deficit hyperactivity disorder.

September 14, 2012

The specialty pharmacy operated by Omnicare Specialty Care Group has been added to the limited distribution network for a drug used to treat a hereditary degenerative disorder.

September 14, 2012

Costs are the biggest concern for opponents of healthcare reform. They’ve done the math — additional healthcare consumers means care that’s both more expensive and harder to come by. As many as 3-in-4 consumers who are not big fans of healthcare reform share that concern — 30% of those consumers suggested it’s their greatest concern, according to an exclusive survey of nearly 800 patients conducted by AccentHealth and DSN in late July and early August. A reduction in care quality was concern No. 2 (62%), and a lack of choice over which practitioner to see was concern No. 3 (58%). But at least they’ll still be covered — only 22% said they were concerned their employers would stop the coverage.

September 14, 2012

Walgreens announced plans to close more than half of the stores it is acquiring in its deal with USA Drug.

September 13, 2012

The Food and Drug Administration has approved a generic psychiatric drug made by Lupin Pharmaceuticals, Lupin said Thursday.

September 13, 2012

The Food and Drug Administration has approved a new drug for multiple sclerosis.

September 13, 2012

Pfizer has inked a deal with a Chinese drug maker to make branded-generic drugs for China and global markets, the companies said.